715 related articles for article (PubMed ID: 21249304)
1. Chagas disease: Present status of pathogenic mechanisms and chemotherapy.
Maya JD; Orellana M; Ferreira J; Kemmerling U; López-Muñoz R; Morello A
Biol Res; 2010; 43(3):323-31. PubMed ID: 21249304
[TBL] [Abstract][Full Text] [Related]
2. Current status of Chagas disease chemotherapy.
Guedes PM; Silva GK; Gutierrez FR; Silva JS
Expert Rev Anti Infect Ther; 2011 May; 9(5):609-20. PubMed ID: 21609270
[TBL] [Abstract][Full Text] [Related]
3. Treatment with benznidazole during the chronic phase of experimental Chagas' disease decreases cardiac alterations.
Garcia S; Ramos CO; Senra JF; Vilas-Boas F; Rodrigues MM; Campos-de-Carvalho AC; Ribeiro-Dos-Santos R; Soares MB
Antimicrob Agents Chemother; 2005 Apr; 49(4):1521-8. PubMed ID: 15793134
[TBL] [Abstract][Full Text] [Related]
4. Trypanocidal drugs for late-stage, symptomatic Chagas disease (Trypanosoma cruzi infection).
Vallejo M; Reyes PP; Martinez Garcia M; Gonzalez Garay AG
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD004102. PubMed ID: 33305846
[TBL] [Abstract][Full Text] [Related]
5. [Chronic Chagas' disease: effects of treatment nn the levels of antibodies to crude and partially purified Trypanosoma cruzi antigens].
Moretti E; Cervetta L; Basso B; Castro I; Santamarina N
Bol Chil Parasitol; 1998; 53(1-2):3-9. PubMed ID: 9830716
[TBL] [Abstract][Full Text] [Related]
6. Vaccine-Linked Chemotherapy Improves Benznidazole Efficacy for Acute Chagas Disease.
Jones K; Versteeg L; Damania A; Keegan B; Kendricks A; Pollet J; Cruz-Chan JV; Gusovsky F; Hotez PJ; Bottazzi ME
Infect Immun; 2018 Apr; 86(4):. PubMed ID: 29311242
[TBL] [Abstract][Full Text] [Related]
7. Treatment with benznidazole or thioridazine in the chronic phase of experimental Chagas disease improves cardiopathy.
Bustamante JM; Presti MS; Rivarola HW; Fernández AR; Enders JE; Fretes RE; Paglini-Oliva P
Int J Antimicrob Agents; 2007 Jun; 29(6):733-7. PubMed ID: 17395432
[TBL] [Abstract][Full Text] [Related]
8. Chagas disease. American trypanosomiasis.
Kirchhoff LV
Infect Dis Clin North Am; 1993 Sep; 7(3):487-502. PubMed ID: 8254156
[TBL] [Abstract][Full Text] [Related]
9. American trypanosomiasis (Chagas disease).
Rassi A; Rassi A; Marcondes de Rezende J
Infect Dis Clin North Am; 2012 Jun; 26(2):275-91. PubMed ID: 22632639
[TBL] [Abstract][Full Text] [Related]
10. Nifurtimox chemotherapy: collateral effects in treated Trypanosoma cruzi infected patients.
Murcia L; Carrilero B; Albajar Viñas P; Segovia M
Rev Esp Quimioter; 2012 Mar; 25(1):74-5. PubMed ID: 22488545
[No Abstract] [Full Text] [Related]
11. [The chemotherapy of Chagas disease].
Stoppani AO
Medicina (B Aires); 1999; 59 Suppl 2():147-65. PubMed ID: 10668258
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of Trypanosoma cruzi infection in the indeterminate phase: experience and current guidelines in Argentina].
Sosa Estani S; Segura EL
Medicina (B Aires); 1999; 59 Suppl 2():166-70. PubMed ID: 10668259
[TBL] [Abstract][Full Text] [Related]
13. Side effects of benznidazole as treatment in chronic Chagas disease: fears and realities.
Viotti R; Vigliano C; Lococo B; Alvarez MG; Petti M; Bertocchi G; Armenti A
Expert Rev Anti Infect Ther; 2009 Mar; 7(2):157-63. PubMed ID: 19254164
[TBL] [Abstract][Full Text] [Related]
14. Update in treatment of Chagas disease.
Le Loup G; Pialoux G; Lescure FX
Curr Opin Infect Dis; 2011 Oct; 24(5):428-34. PubMed ID: 21857512
[TBL] [Abstract][Full Text] [Related]
15. Antitrypanosomal therapy for chronic Chagas' disease.
Bern C
N Engl J Med; 2011 Jun; 364(26):2527-34. PubMed ID: 21714649
[No Abstract] [Full Text] [Related]
16. Course of Chronic Trypanosoma cruzi Infection after Treatment Based on Parasitological and Serological Tests: A Systematic Review of Follow-Up Studies.
Sguassero Y; Cuesta CB; Roberts KN; Hicks E; Comandé D; Ciapponi A; Sosa-Estani S
PLoS One; 2015; 10(10):e0139363. PubMed ID: 26436678
[TBL] [Abstract][Full Text] [Related]
17. Activity of the new triazole derivative albaconazole against Trypanosoma (Schizotrypanum) cruzi in dog hosts.
Guedes PM; Urbina JA; de Lana M; Afonso LC; Veloso VM; Tafuri WL; Machado-Coelho GL; Chiari E; Bahia MT
Antimicrob Agents Chemother; 2004 Nov; 48(11):4286-92. PubMed ID: 15504854
[TBL] [Abstract][Full Text] [Related]
18. Comparative efficacies of TAK-187, a long-lasting ergosterol biosynthesis inhibitor, and benznidazole in preventing cardiac damage in a murine model of Chagas' disease.
Corrales M; Cardozo R; Segura MA; Urbina JA; Basombrío MA
Antimicrob Agents Chemother; 2005 Apr; 49(4):1556-60. PubMed ID: 15793138
[TBL] [Abstract][Full Text] [Related]
19. [Update on the treatment of Chagas' disease].
Apt W; Zulantay I
Rev Med Chil; 2011 Feb; 139(2):247-57. PubMed ID: 21773664
[TBL] [Abstract][Full Text] [Related]
20. Chronic Chagas' disease in the mouse. IV. Effect of trypanocidal drugs.
Laguens RP; Cabeza Meckert P; Chambó JG; Gelpi R
Medicina (B Aires); 1983; 43(2):126-30. PubMed ID: 6420640
[No Abstract] [Full Text] [Related]
[Next] [New Search]
